NY1 covered World Hepatitis Day 2015, with a focus on Hep C in the Bronx and the Project INSPIRE Hep C Care Coordination program, in the segment on their English and Spanish language channels.
Last Updated on January 25, 2020 by HepFree NYC
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
Last Updated on January 25, 2020 by HepFree NYC
Help us launch the Hep Free NYC LGBTQ Initiative by completing a short survey here. This survey allows hepatitis and LGBTQ organizations give advice and recommendations on how we can create an impactful and successful initiative.
The Hepatitis A, B and C in NYC: 2022 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
New York State (NYS) Removal of Prior Authorization for Hep C Medications Frequently Asked Questions 1. Are insurance companies aware of this change? Yes, insurance companies (Medicaid Managed Care plans, MMC) are aware of this change. On July 23, 2020, the New Yor...
The US Preventative Screening Task Force (USPSTF) has begun the process for developing HBV screening recommendations.
In NYC, many Hep C patients with a positive Hep C antibody test do not get the Hep C RNA test needed to confirm infection (McGibbon et al, 2013). Clinicians can now order a Hep C antibody test with reflex to RNA from several commercial laboratories. The reflex test confirms c...
Hep C Mentor and Support Group (HCMSG) developed a virtual training that provides a free overview of Hep C Basics and HCMSG’s Circle Model.
The New York State Department of Health (NYSDOH) Commissioner’s Special Recognition Awards will remain virtual for 2022, and take place on Thursday, December 1 at 2:00 pm. The NYSDOH is seeking nominations for the 2022 World AIDS Day Commissioner’s Special Recognition Award...
On Feb 26th, 2015, the NYS Drug Utilization Review Board (DURB) voted unanimously to move Viekira Pak to preferred status for NYS Medicaid Fee-for-service members, and to remove restrictions based on disease prognosis and severity from the current clinical criteria for Viekira Pa...

We (hepfree.nyc) and selected third parties (7) collect personal information as specified in the privacy policy and use cookies or similar technologies for technical purposes and, with your consent, for functionality, experience, measurement and marketing (personalized ads).
You can freely give, deny, or withdraw your consent at any time by accessing the preferences panel. Denying consent may make related features unavailable.
Use the "Accept all" button to consent. Use the "Reject all" button to continue without accepting.
In this panel you can express preferences for the processing of your personal information. You may review and change your choices at any time.